Valproate (Epilepsy) updated on 04-22-2025

Severe cognitive developmental delay (Mental retardation) (> 6 years old)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17439
R73279
Madley-Dowd_SE (Valproate) (Controls exposed to LTG), 2024 Intellectual disability (intelligence quotient below 70) - ICD-8/9/10 codes - Mean 5-20 years old (according groups° during pregnancy (anytime or not specified) population based cohort retrospective exposed to other treatment, sick excluded Adjustment: No Partial overlapping 4.76 [3.06;7.40] C
excluded (control group)
51/792   34/2,383 85 792
ref
S17440
R73285
Madley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024 Intellectual disability (intelligence quotient below 70) - ICD-8/9/10 codes - Mean 5-20 years old (according groups) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: Yes Partial overlapping 2.81 [2.05;3.85] 51/792   194/10,769 245 792
ref
S17256
R72220
Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024 Intellectual disability - ICD10 codes - Median follow up 9.32 (5.54-12.83) years old during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed, sick Adjustment: Yes 1.35 [0.28;6.56] -/354   13/4,075 - 354
ref
S15877
R65486
Dreier (Valproate) (Epilepsy) (Controls exposed to LTG), 2023 Intellectual disability - Corresponding ICD-10 F-chapter - Up to 22 years of age during pregnancy (anytime or not specified) population based cohort propective exposed to other treatment, sick excluded Adjustment: No 6.69 [4.47;10.02] C
excluded (control group)
81/1,952   34/5,288 115 1,952
ref
S15878
R65476
Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023 Intellectual disability - Corresponding ICD-10 F-chapter - Up to 22 years of age during pregnancy (anytime or not specified) population based cohort propective unexposed, sick Adjustment: Yes 2.70 [1.94;3.74] 81/1,952   184/22,203 265 1,952
ref
S7304
R21154
Meador (Valproate), 2013 IQ <70 (DAS) (at 6 years old) during pregnancy (anytime or not specified) prospective cohort exposed to other treatment, sick Adjustment: Yes 7.90 [0.37;168.31] C 2/49   0/74 2 49
ref
S6123
R15992
Titze (Valproate) (Controls unexposed, disease free), 2008 Learning disability (IQ<70) (German versions of the revised Wechsler Intelligence Scales for children and for adults) during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: No Matched 19.40 [0.31;1195.39] C
excluded (control group)
0/3   0/49 0 3
ref
S6124
R15993
Titze (Valproate) (Controls unexposed, sick), 2008 Learning disability (IQ<70) (German versions of the revised Wechsler Intelligence Scales for children and for adults) during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No 1.53 [0.05;49.80] C 0/3   1/13 1 3
ref
S5543
R14427
Viinikainen (Valproate) b, 2006 Full Scale IQ (FIQ) < 2SD Wechsler Intelligence Scale for Children (WISC III) throughout pregnancy prospective cohort unexposed, sick Adjustment: No Matched 5.95 [0.26;138.26] C 2/13   0/13 2 13
ref
S6782
R19153
Vinten (Valproate), 2005 IQ score <69 Wechsler Intelligence Scale for Children (WISC III) (Aged between 6 and 16 years) during pregnancy (anytime or not specified) retrospective cohort unexposed, sick Adjustment: No 3.47 [1.14;10.56] C 9/41   6/80 15 41
ref
S7235
R20860
Gaily (Valproate) (Controls unexposed, disease free), 2004 Mental retardation (Verbal and nonverbal IQ <70) 2nd and/or 3rd trimester prospective cohort unexposed, disease free Adjustment: No 3.83 [0.37;39.75] C 1/13   3/141 4 13
ref
Total 8 studies 2.77 [2.23;3.44] 534 3,217
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Madley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024Madley-Dowd_SE, 2024 1 2.81[2.05; 3.85]24579248%ROB confusion: moderateROB selection: lowROB classification: lowROB missing: lowROB mesure: criticalROB reporting: moderate Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024Madley-Dowd_UK, 2024 2 1.35[0.28; 6.56]-3542%ROB confusion: moderateROB selection: lowROB classification: criticalROB missing: unclearROB mesure: criticalROB reporting: moderate Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023Dreier, 2023 3 2.70[1.94; 3.74]2651,95244%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: lowROB mesure: criticalROB reporting: moderate Meador (Valproate), 2013Meador, 2013 4 7.90[0.37; 168.31]2491%ROB confusion: moderateROB selection: lowROB classification: lowROB missing: moderateROB mesure: lowROB reporting: low Titze (Valproate) (Controls unexposed, sick), 2008Titze, 2008 5 1.53[0.05; 49.80]130%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: moderateROB mesure: moderateROB reporting: moderate Viinikainen (Valproate) b, 2006Viinikainen, 2006 6 5.95[0.26; 138.26]2130%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: moderateROB mesure: lowROB reporting: moderate Vinten (Valproate), 2005Vinten, 2005 7 3.47[1.14; 10.56]15414%ROB confusion: criticalROB selection: criticalROB classification: lowROB missing: criticalROB mesure: lowROB reporting: moderate Gaily (Valproate) (Controls unexposed, disease free), 2004Gaily, 2004 8 3.83[0.37; 39.75]4131%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: criticalROB mesure: lowROB reporting: moderate Total (8 studies) I2 = 0% 2.77[2.23; 3.44]5343,2170.520.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Valproate) (Controls unexposed, sick; 2: Valproate) (Controls unexposed, sick) (Epilepsy; 3: Valproate) (Epilepsy) (Controls unexposed, sick; 4: Valproate; 5: Valproate) (Controls unexposed, sick; 6: Valproate) ; 7: Valproate; 8: Valproate) (Controls unexposed, disease free;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.77[2.23; 3.44]5343,2170%NAMadley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024 Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024 Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023 Meador (Valproate), 2013 Titze (Valproate) (Controls unexposed, sick), 2008 Viinikainen (Valproate) b, 2006 Vinten (Valproate), 2005 Gaily (Valproate) (Controls unexposed, disease free), 2004 8 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 3.83[0.37; 39.75]413 -NAGaily (Valproate) (Controls unexposed, disease free), 2004 1 unexposed, sickunexposed, sick 2.75[2.21; 3.42]5283,1550%NAMadley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024 Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024 Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023 Titze (Valproate) (Controls unexposed, sick), 2008 Viinikainen (Valproate) b, 2006 Vinten (Valproate), 2005 6 exposed to other treatment, sickexposed to other treatment, sick 7.90[0.37; 168.31]249 -NAMeador (Valproate), 2013 1 Tags Adjustment   - No  - No 3.48[1.38; 8.77]22700%NATitze (Valproate) (Controls unexposed, sick), 2008 Viinikainen (Valproate) b, 2006 Vinten (Valproate), 2005 Gaily (Valproate) (Controls unexposed, disease free), 2004 4   - Yes  - Yes 2.73[2.18; 3.42]5123,1470%NAMadley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024 Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024 Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023 Meador (Valproate), 2013 4 MatchedMatched 5.95[0.26; 138.26]213 -NAViinikainen (Valproate) b, 2006 1 Partial overlappingPartial overlapping 2.81[2.05; 3.85]245792 -NAMadley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024 1 All studiesAll studies 2.77[2.23; 3.44]5343,2170%NAMadley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024 Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024 Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023 Meador (Valproate), 2013 Titze (Valproate) (Controls unexposed, sick), 2008 Viinikainen (Valproate) b, 2006 Vinten (Valproate), 2005 Gaily (Valproate) (Controls unexposed, disease free), 2004 80.520.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-4.25.22.1310.000Madley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023Meador (Valproate), 2013Titze (Valproate) (Controls unexposed, sick), 2008Viinikainen (Valproate) b, 2006Vinten (Valproate), 2005Gaily (Valproate) (Controls unexposed, disease free), 2004

Asymetry test p-value = 0.6476 (by Egger's regression)

slope=0.9900 (0.0852); intercept=0.1302 (0.2707); t=0.4809; p=0.6476

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded 6123, 15877, 17439

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 5.69[0.74; 43.50]4160%NATitze (Valproate) (Controls unexposed, disease free), 2008 Gaily (Valproate) (Controls unexposed, disease free), 2004 2 unexposed, sick controlsunexposed, sick controls 2.75[2.21; 3.42]5323,1550%NAMadley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024 Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024 Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023 Titze (Valproate) (Controls unexposed, sick), 2008 Viinikainen (Valproate) b, 2006 Vinten (Valproate), 2005 6 exposed to other treatment, sick controlsexposed to other treatment, sick controls 5.74[4.27; 7.73]2022,7930%NAMadley-Dowd_SE (Valproate) (Controls exposed to LTG), 2024 Dreier (Valproate) (Epilepsy) (Controls exposed to LTG), 2023 Meador (Valproate), 2013 30.510.01.0